314 results match your criteria: "Principality of Liechtenstein; Drexel University College of Medicine[Affiliation]"

Uromodulin is a protein which is produced by the tubular cells of the thick ascending limb in the kidneys and the creatinine to uromodulin ratio in serum recently has attracted interest as a marker of kidney disease. Whether this ratio also is associated with cardiovascular event risk is unknown. This article provides additional data on the association of the creatinine to uromodulin ratio with its power to predict cardiovascular events and major cardiovascular events in coronary patients.

View Article and Find Full Text PDF

Background: Uromodulin is the most abundant protein in urine. Low uromodulin has been found associated with diabetes as well as with chronic kidney disease (CKD). Whether it also predicts a future decline in kidney function is not known.

View Article and Find Full Text PDF

Background: Lipoprotein(a) concentrations in plasma are associated with cardiovascular risk in the general population. Whether lipoprotein(a) concentrations or LPA genetic variants predict long-term mortality in patients with established coronary heart disease remains less clear.

Methods: We obtained data from 3313 patients with established coronary heart disease in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

View Article and Find Full Text PDF

Organizations are increasingly using sustainability reports to inform their stakeholders and the public about their sustainability practices. We apply topic modelling to 9,514 sustainability reports published between 1999 and 2015 in order to identify common topics and, thus, the most common practices described in these reports. In particular, we identify forty-two topics that reflect sustainability and focus on the coverage and trends of economic, environmental, and social sustainability topics.

View Article and Find Full Text PDF

Background: The aim of this study was to assess the relationships between healthy lifestyle metrics and blood pressure variability (BPV) in young and healthy adults.

Methods: A population-based sample of 1,999 individuals aged 25-41 years was investigated. A lifestyle-score from 0 (most unhealthy) to 7 (most healthy) was calculated by giving one point for each of the following components: never smoking cigarettes, adhering to a healthy diet, performing moderate or intense physical activity, having a body mass index <25 kg/m2, a total cholesterol <200 mg/dl, a glycated hemoglobin <5.

View Article and Find Full Text PDF

A commentary on the new ESC guidelines on dyslipidaemias.

Eur Heart J Cardiovasc Pharmacother

April 2017

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Academic Teaching Hospital Feldkirch, Carinagasse 47, Feldkirch, A-6800 Austria.

View Article and Find Full Text PDF

Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature.

J Eur Acad Dermatol Venereol

October 2017

Dermatology Practice Schaffhauserplatz, Zurich, Switzerland.

Background: Unilesional mycosis fungoides (UMF) and pagetoid reticulosis (PR) are variants of mycosis fungoides. Conventional therapy comprises surgical excision or radiotherapy, which may be associated with long-term side effects, especially when the lesion is located at a special site like the palms and soles. Therefore, alternative treatment options are needed to treat solitary lesions in the case of UMF or PR.

View Article and Find Full Text PDF

Serum uromodulin is associated with impaired glucose metabolism.

Medicine (Baltimore)

February 2017

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria Private University of the Principality of Liechtenstein, Triesen, Liechtenstein Medical Central Laboratories, Academic Teaching Hospital Feldkirch, Feldkirch, Austria Department of Medicine and Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria Drexel University College of Medicine, Philadelphia, PA, USA.

Uromodulin is the most abundant urine protein under physiological conditions. It has recently been described as a serum and plasma marker for kidney disease. Whether uromodulin is associated with impaired glucose metabolism is unknown.

View Article and Find Full Text PDF

Serum uromodulin is a predictive biomarker for cardiovascular events and overall mortality in coronary patients.

Int J Cardiol

March 2017

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria; Department of Medicine and Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein; Drexel University College of Medicine, Philadelphia, PA, USA. Electronic address:

Background: Uromodulin is a protein produced exclusively by the kidneys and present in urine and blood. In contrast to weak and in part contradictory study data on uromodulin in urine samples, the analysis of serum samples recently proved uromodulin's value as superior biomarker for ongoing kidney disease. Whether serum uromodulin is associated with cardiovascular event risk and whether it has predictive power for overall mortality is still unknown and has been evaluated in the present study.

View Article and Find Full Text PDF

Relationships of Measured and Genetically Determined Height With the Cardiac Conduction System in Healthy Adults.

Circ Arrhythm Electrophysiol

January 2017

From the Division of Internal Medicine, Department of Medicine (T.K., S.A., P.K., S.B., D.C.), Cardiovascular Research Institute Basel (T.K., M.B., S.A., S.B., P.K., S.B., D.C.), and Cardiology Division, Department of Medicine (M.B.), University Hospital Basel, Switzerland; Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute (S.T., M.B., G.P., D.C.) and Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine (S.T., G.P.), McMaster University, Hamilton, Ontario, Canada; Division of Cardiology, Hamilton General Hospital, Hamilton Health Sciences, Canada (M.B.); Labormedizinisches Zentrum Dr. Risch, Schaan, Principality of Liechtenstein (M.R., L.R.); Division of Laboratory Medicine, Kantonspital Graubünden, Chur, Switzerland (M.R.); Division of Clinical Biochemistry, Medical University, Innsbruck, Austria (L.R.); Private University, Triesen, FL (L.R.); and Center for Arrhythmia Prevention, Division of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (C.M.A.).

Background: Increasing height is an independent risk factor for atrial fibrillation, but the underlying mechanisms are unknown. We hypothesized that height-related differences in electric conduction could be potential mediators of this relationship.

Methods And Results: We enrolled 2149 adults aged 25 to 41 years from the general population.

View Article and Find Full Text PDF

Data presented here refer to 57,885 patients on lipid-lowering statin therapy from the Dyslipidaemia International Study (DYSIS) registry. Subjects were divided into 3 discrete subsets: those at very high-risk, high-risk, and non-high-risk for cardiovascular events, with assigned low density lipoprotein cholesterol (LDL-C) targets of 70 mg/dl, 100 mg/dl and 115 mg/dl, respectively. Overall, the highest proportion of patients meeting their LDL-C target was seen in the UAE and Kuwait (49.

View Article and Find Full Text PDF

Impact of diet and exercise on proprotein convertase subtilisin/kexin 9: A mini-review.

Vascul Pharmacol

December 2016

Department of Medicine and Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria; Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein; Drexel College University of Medicine, Philadelphia, PA, USA. Electronic address:

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) plays an important role in the regulation of blood cholesterol levels, and inhibition of PCSK9 with monoclonal antibodies reduces LDL cholesterol by more than 50% over and above what can be achieved with statins or ezetimibe alone. Diet and exercise influence PCSK9 levels; however data on this issue are scarce. Regarding diet, a high oleic canola/docosahexaenoic acid oil blend, marine n-3 polyunsaturated fatty acids, vegetable n-6 polyunsaturated fatty acids, a Mediterranean style diet and acute fasting, but not necessarily weight reduction are associated with low PCSK9 concentrations, whereas a high fructose diet is associated with high PCSK9 concentrations.

View Article and Find Full Text PDF

Background And Aims: There is an inconsistency between international guidelines on lipid-lowering treatment regarding whether to pursue LDL-C treatment targets or to focus on the intensity of treatment. While either approach is attractive, there is no recent global data on actual LDL-C values, treatment targets attained, and the intensity of treatment in statin-treated patients. We aimed to determine and compare the extent of treatment target attainment globally using standardized data collection.

View Article and Find Full Text PDF

High-Dose Benzodiazepine Users' Perceptions and Experiences of Anterograde Amnesia.

J Am Acad Psychiatry Law

September 2016

Dr. Liebrenz is Head of the Research Division, Department of Forensic Psychiatry, Institute of Forensic Medicine, University of Bern, Bern, Switzerland. Mr. Schneider is Resident Physician, Department of Surgery, Division of Visceral and Transplantation Surgery, University Hospital, Zurich, Switzerland. Dr. Buadze is Attending Physician, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland. Ms. Gehring is a Psychologist and Head of the Residential Rehabilitation Treatment Program, Ulmenhof, Sozialtherapie, Ottenbach, Switzerland. Dr. Dube is Attending Physician, County of Santa Barbara, Department of Behavioral Wellness, Santa Barbara, California. Dr. Caflisch is Attending Physician, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland. Dr. Liebrenz was financially supported by the Prof. Dr. Max Cloëtta Foundation, Zurich, Switzerland and the Uniscientia Foundation, Vaduz, Principality of Liechtenstein.

Associations between criminal activity and the use of psychotropic substances are well established. Flunitrazepam, specifically, has been suspected of triggering, per se, violent criminal behavior and severe memory disturbances in the form of anterograde amnesia. However, data from investigations of this relationship are scarce and have been primarily derived from forensic institutions, where there may be a reporting bias.

View Article and Find Full Text PDF

Heart Rate Variability and Sleep-Related Breathing Disorders in the General Population.

Am J Cardiol

September 2016

Division of Internal Medicine, Department of Medicine, University Hospital Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland. Electronic address:

Obstructive sleep apnea seems to have an important influence on the autonomic nervous system. In this study, we assessed the relations of sleep apnea-related parameters with 24-hour heart rate variability (HRV) in a large population of young and healthy adults. Participants aged 25 to 41 years with a body mass index <35 kg/m(2) and without known obstructive sleep apnea were included in a prospective population-based cohort study.

View Article and Find Full Text PDF

Background: Determinants of cardiomyocyte injury as quantified by high-sensitivity cardiac troponin I (cTnI) in young and healthy individuals, and sex-specific 99th percentiles are largely unknown.

Methods: Our study included 2077 adults from the general population aged 25-41 years without cardiovascular disease. cTnI was measured using a high-sensitivity assay.

View Article and Find Full Text PDF

Background: Heart rate (HR), heart rate variability (HRV), and inflammation are all associated with cardiovascular morbidity and mortality. The aim of this study was to assess potential interrelationships between these parameters in a young and healthy population.

Methods: Healthy individuals aged 25-41 years were included in a prospective population-based study.

View Article and Find Full Text PDF

Introduction: Acquired JAK2 as well as calreticulin (CALR) mutations are involved in the development of Philadelphia-negative myeloproliferative neoplasms (MPN). We previously showed that the JAK2 V617F mutation could also been found in coronary patients and in patients with peripheral arterial disease (PAD). However, prevalence of CALR mutations is unknown in vascular risk patients and its evaluation subject of the present study.

View Article and Find Full Text PDF

Quality management in clinical application of mass spectrometry measurement systems.

Clin Biochem

September 2016

Risch Laboratory Group, Schaan, Principality of Liechtenstein.

Thanks to highly specific analyte detection and potentially complete compensation for matrix variables based on the principle of stable isotope derivative internal standardisation, mass spectrometry methods allow the development of diagnostic tests of outstanding analytical quality. However, these features per se do not guarantee reliability of tests. A wide range of factors can introduce analytical errors and inaccuracy due to the extreme complexity of the methods involved.

View Article and Find Full Text PDF

Background: The Asian bush mosquito, Aedes (Hulecoeteomyia) japonicus japonicus (Theobald, 1901) (Diptera: Culicidae), was first identified in Austria in August 2011 in the federal state of Styria at the border to Slovenia.

Methods: Between 2011 and 2015 the spread of Ae. j.

View Article and Find Full Text PDF

Lipoprotein (a), the Metabolic Syndrome and Vascular Risk in Angiographied Coronary Patients.

J Clin Endocrinol Metab

August 2016

Department of Medicine and Cardiology, Vorarlberg Institute for Vascular Investigation and Treatment (A.V., C.H.S., P.R., D.Z, H.D.), Feldkirch 6800, Austria; Department of Medicine and Cardiology (A.V., C.H.S., P.R., D.Z, H.D.), Academic Teaching Hospital Feldkirch, Feldkirch 6800, Austria; Private University of the Principality of Liechtenstein (A.V., C.H.S., P.R., D.Z, H.D.), Triesen 9495, Liechtenstein; Department of Medicine, Drexel University College of Medicine (H.D.), Philadelphia, Pennsylvania 19129.

Background: Lipoprotein (a) [Lp(a)] especially in young individuals, is an important cardiovascular risk factor. However, data on the vascular risk conferred by Lp(a) in patients with the metabolic syndrome (MetS) are not available.

Methods: Lp(a) was measured in a cohort of 593 consecutive patients undergoing coronary angiography for the evaluation of stable coronary artery disease.

View Article and Find Full Text PDF

Obesity is characterized by the rapid expansion of visceral adipose tissue, resulting in a hypoxic environment in adipose tissue which leads to a profound change of gene expression in adipocytes. As a consequence, there is a dysregulation of metabolism and adipokine secretion in adipose tissue leading to the development of systemic inflammation and finally resulting in the onset of metabolic diseases. The flavonoid quercetin as well as other secondary plant metabolites also referred to as phytochemicals have anti-oxidant, anti-inflammatory, and anti-diabetic effects known to be protective in view of obesity-related-diseases.

View Article and Find Full Text PDF

Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee.

Ther Drug Monit

April 2016

*Risch Laboratories Group, Schaan, Principality of Liechtenstein; †Klinikum Stuttgart, Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin, Stuttgart, Germany; ‡iC42 Clinical Research and Development, University of Colorado, Anschutz Medical Campus, Denver; §Pharmacology, APHP, Hôpital Européen G Pompidou, Paris Descartes University, France; ¶Department of Pathology and Genomic Medicine, Houston Methodist Hospital, TX; ‖ASI Ltd, St George's-University of London, United Kingdom; **Pharmacology and Toxicology Laboratory, Biomedical Diagnostic Center (CDB), Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; ††Clinical Pharmacology Unit, Institute of Cardiology, Medical University of Warsaw, Poland; ‡‡Department of Drug Chemistry, Medical University of Warsaw, Poland; §§Department of Laboratory Medicine and Pathology, Mayo Clinic, College of Medicine, Rochester, NY; ¶¶UMR 850 INSERM, University Limoges, CHU Limoges, France; ‖‖Department of Clinical Pharmacology, Georg-August University, University Medical Center Göttingen, Germany; and ***Clinical Chemistry Department, Université Catholique de Louvain, LTAP, Cliniques Universitaires St Luc, Brussels, Belgium.

Article Synopsis
  • Monitoring immunosuppressive drugs (ISDs) in blood is crucial for ensuring patient safety and treatment efficacy due to the narrow therapeutic ranges and potential side effects associated with these medications.
  • Accurate and precise measurements are essential for avoiding drug underexposure or overexposure, which can lead to serious health risks.
  • This overview from the Immunosuppressive Drugs Scientific Committee aims to provide a summary and guidance on the best practices for therapeutic drug monitoring (TDM) of ISDs.
View Article and Find Full Text PDF

Therapeutic Drug Monitoring of Everolimus: A Consensus Report.

Ther Drug Monit

April 2016

*Klinikum Stuttgart, Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin, Stuttgart, Germany; †Department of Internal Medicine, Division of Nephrology and Renal Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; ‡Analytical Services International, London, United Kingdom; §Pharmacology, APHP, Hôpital Européen G Pompidou, Paris Descartes University, Paris, France; Departments of ¶Internal Medicine and ‖Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; **Clinical Pharmacology Unit, Institute of Cardiology, Warsaw, Poland; ††Pharmacology and Toxicology Laboratory, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, University of Barcelona, Spain; ‡‡Medizinische Klinik mit Schwerpunkt Nephrologie, Charité Universitätsmedizin Berlin, Berlin, Germany; §§Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany; ¶¶Hepatobiliary Surgery and Liver Transplantation Unit, University of Pisa Medical Hospital, Pisa, Italy; ‖‖Pharmacology and Toxicology Laboratory (CDB), CIBERehd, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Spain; ***Department of Pharmacy, Kyushu University Hospital, Kyushu University, Fukuoka, Japan; †††Department of Clinical Pharmacology & Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; ‡‡‡Risch Laboratories Group, Schaan, Principality of Liechtenstein; §§§UMR 850 INSERM, University of Limoges, CHU Limoges, Limoges, France; ¶¶¶Department of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany; ‖‖‖Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, College of Medicine, Rochester, MN; ****Clinical Chemistry Department, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium;

Article Synopsis
  • In 2014, an international committee gathered to recommend guidelines for therapeutic drug monitoring (TDM) of everolimus (EVR), focusing on its use in preventing organ rejection and treating certain cancers.
  • EVR has a narrow therapeutic range and varies greatly between individuals, making monitoring crucial; its trough concentrations (C0) offer a reliable measure for TDM, ideally taken from whole-blood samples before the next dose.
  • For transplant patients, the optimal EVR target range is set at 3-8 ng/mL combined with other drugs, while a higher range of 6-10 ng/mL is suggested for those not using calcineurin inhibitors, with further research needed for non-transplant applications.
View Article and Find Full Text PDF